Average Co-Inventor Count = 4.76
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (8 from 4,442 patents)
2. Chiron Corporation (6 from 656 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (3 from 245 patents)
4. Other (1 from 832,680 patents)
5. Novartis Ag (1 from 3,923 patents)
6. Chiron Viagene, Inc. (1 from 9 patents)
20 patents:
1. 10808027 - DNA molecules encoding antibodies to tau and methods of making thereof
2. 10011653 - Antibodies to tau and methods of treatment therewith
3. 9527909 - Antibodies to tau and uses thereof
4. 9422353 - Fibroblast growth factor 21 variant, composition , and uses thereof
5. 8927492 - Fibroblast growth factor 21 proteins
6. 8883726 - Fibroblast growth factor 21 variants
7. 8741841 - Fibroblast growth factor 21 proteins
8. 8647864 - Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
9. 8541369 - Fibroblast growth factor 21 variants having improved pharmacological potency and/or improved pharmaceutical stability
10. 7977091 - Eukaryotic layered vector initiation systems
11. 7771979 - Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
12. 7572628 - Eukaryotic layered vector initiation systems
13. 6376236 - Recombinant alphavirus particles
14. 6342372 - Eukaryotic layered vector initiation systems for production of recombinant proteins
15. 6333195 - Crossless retroviral vectors